BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20009136)

  • 1. The safety and feasibility of large volume paracentesis performed by an experienced nurse practitioner.
    Gilani N; Patel N; Gerkin RD; Ramirez FC; Tharalson EE; Patel K
    Ann Hepatol; 2009; 8(4):359-63. PubMed ID: 20009136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
    Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose albumin for the prevention of renal impairment following large volume paracentesis in cirrhosis.
    Hussain W; Khalid AB; Usmani T; Ghufran A; Shah H
    Pak J Med Sci; 2015; 31(3):592-6. PubMed ID: 26150850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.
    Wong YJ; Lum HM; Tan PT; Teo EK; Tan J; Kumar R; Thurairajah PH
    Singapore Med J; 2021 Dec; 62(12):659-664. PubMed ID: 33866716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
    Stepanova M; Nader F; Bureau C; Adebayo D; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rossi S; MacDonald S; Capel J; Jalan R; Younossi ZM
    Qual Life Res; 2018 Jun; 27(6):1513-1520. PubMed ID: 29460201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance standards for therapeutic abdominal paracentesis.
    Grabau CM; Crago SF; Hoff LK; Simon JA; Melton CA; Ott BJ; Kamath PS
    Hepatology; 2004 Aug; 40(2):484-8. PubMed ID: 15368454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
    Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
    J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
    García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
    Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.
    Allegretti AS; Ortiz G; Cui J; Wenger J; Bhan I; Chung RT; Thadhani RI; Irani Z
    Am J Kidney Dis; 2016 Sep; 68(3):381-91. PubMed ID: 26994685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential hemodynamic changes for large volume paracentesis in post-hepatitic cirrhotic patients with massive ascites.
    Wang SS; Chen CC; Chao Y; Wu SL; Lee FY; Lin HC; Kong CW; Tsai YT; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Oct; 20(4):117-22. PubMed ID: 9050257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Caldwell needle/cannula with Angiocath needle in large volume paracentesis.
    Shaheen NJ; Grimm IS
    Am J Gastroenterol; 1996 Sep; 91(9):1731-3. PubMed ID: 8792689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.
    Jeffries MA; Stern MA; Gunaratnam NT; Fontana RJ
    Am J Gastroenterol; 1999 Oct; 94(10):2972-6. PubMed ID: 10520854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incarceration of umbilical hernia: a rare complication of large volume paracentesis.
    Khodarahmi I; Shahid MU; Contractor S
    J Radiol Case Rep; 2015 Sep; 9(9):20-5. PubMed ID: 26629305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-paracentesis circulatory derangements are related to monocyte activation.
    Carl DE; Ghosh S; Cheng J; Gehr TW; Stravitz RT; Sanyal A
    Liver Int; 2014 Aug; 34(7):1001-7. PubMed ID: 24373155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
    Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
    J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis.
    Cheng YW; Sandrasegaran K; Cheng K; Shah A; Ghabril M; Berry W; Lammert C; Chalasani N; Orman ES
    Abdom Radiol (NY); 2018 Aug; 43(8):2190-2197. PubMed ID: 29188319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardizing the Use of Albumin in Large Volume Paracentesis.
    Anderson SS; McCreary JB; Alvarez KS; Brown LS; Agrawal D
    J Pharm Pract; 2020 Aug; 33(4):420-424. PubMed ID: 30522384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.
    Elsabaawy MM; Abdelhamid SR; Alsebaey A; Abdelsamee E; Obada MA; Salman TA; Rewisha E
    Clin Mol Hepatol; 2015 Dec; 21(4):365-71. PubMed ID: 26770925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.